# Botulin-A Toxin Instillations and Overactive Bladder

> **NCT00583219** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 25 (actual)

## Conditions studied

- Overactive Bladder
- Detrusor Instability
- Detrusor Hyperreflexia

## Interventions

- **DRUG:** Botulinum-A toxin
- **DRUG:** Dimethyl sulfoxide (DMSO)

## Key facts

- **NCT ID:** NCT00583219
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00583219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00583219, "Botulin-A Toxin Instillations and Overactive Bladder". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00583219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*